Angel Ramos

Angel Ramos is a skilled chemist with extensive experience in medicinal and process chemistry. Currently serving as a Senior Research Associate II at Eikon Therapeutics, Angel transitioned from medicinal chemistry to process chemistry in August 2023. Prior roles include Research Scientist positions at Eurofins Alphora and ALPHORA RESEARCH, and a Chief Technology Officer role at Intensive Dietary Management. Angel has developed significant expertise in synthetic organic chemistry, process optimization, and regulatory compliance, notably at Gilead Sciences, where contributions supported the manufacturing of Voxilaprevir API for clinical studies. Educational qualifications include a Master of Science in Chemistry from the University of Oregon and a Bachelor of Science in Chemistry from the University of Central Florida.